UnknownNot Applicable

Long-term Outcome of Triple-vessel Coronary Artery Disease Underwent Three Different Strategies (LOTUS)

China10,000 participantsStarted 2004-04

Plain-language summary

The study is to determine the long-term outcome of patients with coronary triple vessels disease (TVD) in the real world of China, by three different treatment strategies: percutaneous coronary intervention (PCI), Coronary artery bypass graft (CABG) or optimal medication therapy (OMT).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject has coronary angiography confirmed triple-vessel disease.
✓. Subject is ≥ 18 years of age at the time of inclusion.
✓. Subject is willing to comply with all protocol-required follow-up evaluation (patient will be followed during 1 month after hospital to assess any complications and clinical status).

Exclusion criteria

✕. Subject is participating in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
✕. Female subjects with a positive quantitative or qualitative pregnancy test, in accordance with hospital policy.
✕. Subjects with no way contact by telephone for follow-up.

What they're measuring

All-cause mortality

Timeframe: Through study completion, an average of 5 year

Trial details

NCT IDNCT02634086

SponsorChinese Academy of Medical Sciences, Fuwai Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-04

Contact for this trial

Lei Song, MD

+86-13910968125 drsongfw@gmail.com

View on ClinicalTrials.gov More Coronary Artery Disease trials